Clinical Trial Update: Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05 [Phase 2]

View source ↗

Summary

Aires Pharmaceuticals reports termination of a long-term Phase 2 study of AIR001 in adults with WHO Group 1 pulmonary arterial hypertension who completed AIR001…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• AIR001

Snippet

Sponsor: Aires Pharmaceuticals, Inc. | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: TERMINATED